Profund Advisors’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $776K | Sell |
27,324
-3,450
| -11% | -$98K | 0.03% | 358 |
|
|
2025
Q1 | $908K | Sell |
30,774
-4,207
| -12% | -$124K | 0.04% | 313 |
|
|
2024
Q4 | $1.02M | Sell |
34,981
-4,990
| -12% | -$145K | 0.04% | 291 |
|
|
2024
Q3 | $1.84M | Buy |
39,971
+18,545
| +87% | +$852K | 0.07% | 203 |
|
|
2024
Q2 | $875K | Sell |
21,426
-10,627
| -33% | -$434K | 0.03% | 334 |
|
|
2024
Q1 | $818K | Sell |
32,053
-707
| -2% | -$18K | 0.03% | 409 |
|
|
2023
Q4 | $296K | Sell |
32,760
-22,961
| -41% | -$208K | 0.01% | 789 |
|
|
2023
Q3 | $356K | Sell |
55,721
-42,984
| -44% | -$274K | 0.02% | 581 |
|
|
2023
Q2 | $1.09M | Buy |
98,705
+41,340
| +72% | +$458K | 0.06% | 297 |
|
|
2023
Q1 | $881K | Buy |
+57,365
| New | +$881K | 0.05% | 330 |
|